Concepedia

Narendra S. Kishnani

NS

10

Publications

696

Citations

10

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California, San Francisco

Bristol-Myers Squibb (United States)

Narendra S. Kishnani is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and pathology.

Top concepts

Publications per year

1992–2018

10

Publications

10

A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family.

Nadine Pavloff, Paul W. Staskus, Narendra S. Kishnani et al. · Journal of Biological Chemistry · 1992 · 271 citations · Full text

, , +19

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

Colin P. Dinney, Mark B. Fisher, Neema Navai et al. · The Journal of Urology · 2013 · 120 citations · Full text

Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor

Anima Ghosal, Yuan Yuan, Wei Tong et al. · Drug Metabolism and Disposition · 2010 · 70 citations

Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist

Anima Ghosal, Xiaowen Lu, Natalia A. Penner et al. · Drug Metabolism and Disposition · 2010 · 50 citations

Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix

Karen Yeow, Narendra S. Kishnani, Mike Hutton et al. · Matrix Biology · 2002 · 48 citations

, , +9

Rows per page

1–5 of 10